Go Deep
Thyrocare Technologies Limited
Thyrocare Technologies Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,329 | 48.1 | 14.40 | 0.09 | 529.80 |
| Oct 2026 | 17,299 | 45.3 | 13.58 | 0.09 | 499.70 |
Thyrocare Technologies Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,400,200,000.0 | 2,239,500,000.0 | 1,955,300,000.0 | — |
| Net Profit | 521,900,000.0 | 471,200,000.0 | 290,100,000.0 | — |
| EPS | 3.2 | 3.0 | 1.8 | 3.0 |
Thyrocare Technologies Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 8,218,900,000.0 | 6,807,100,000.0 | 5,678,800,000.0 | 5,172,000,000.0 |
| Net Profit | 1,630,400,000.0 | 915,100,000.0 | 707,600,000.0 | 644,900,000.0 |
| EPS | 10.2 | 5.8 | 4.5 | 4.1 |
Thyrocare Technologies Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 7,472,200,000.0 | 6,927,500,000.0 | 6,438,800,000.0 | 6,327,200,000.0 | — |
| Total Liabilities | 1,612,000,000.0 | 1,456,900,000.0 | 1,162,500,000.0 | 975,000,000.0 | — |
| Total Equity | 5,855,000,000.0 | 5,467,600,000.0 | 5,267,700,000.0 | 5,343,000,000.0 | — |
Owes vs Owns
Thyrocare Technologies Limited owed ₹0.22 for every ₹1 it owned in Mar 2026, up from ₹0.15 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.22× | 0.21× | 0.18× | 0.15× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Thyrocare Technologies Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 30.9%Receivables 9.9%Inventory 6.5%Fixed assets (tangible) 27.9%Intangible assets 15.0%Long-term investments 3.4%Other assets 6.4%
How it's funded — Mar 2026
Short-term debt 1.5%Long-term debt 5.2%Payables 8.7%Other liabilities 6.0%Shareholders' equity 78.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 231.1 | 191.8 | 176.6 | 150.8 |
| Receivables | 73.9 | 73.0 | 43.5 | 85.1 |
| Inventory | 48.5 | 46.5 | 47.5 | 27.7 |
| Fixed assets (tangible) | 208.7 | 198.3 | 203.7 | 194.4 |
| Intangible assets | 111.8 | 113.0 | 104.7 | 101.1 |
| Long-term investments | 25.1 | 24.2 | 25.6 | 22.1 |
| Other assets | 48.1 | 45.9 | 42.2 | 51.6 |
| Liabilities & equity | ||||
| Short-term debt | 11.5 | 0.0 | 10.7 | 0.0 |
| Long-term debt | 39.2 | 0.0 | 10.9 | 0.0 |
| Payables | 65.4 | 76.2 | 40.1 | 24.0 |
| Other liabilities | 45.1 | 69.5 | 54.5 | 73.5 |
| Shareholders' equity | 586.0 | 547.1 | 527.6 | 535.2 |
| Net tangible assets | 473.7 | 433.7 | 422.1 | 433.2 |
Thyrocare Technologies Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,132,400,000.0 | 1,799,100,000.0 | 1,676,300,000.0 | 1,293,100,000.0 | — |
| Investing Activities | -230,100,000.0 | -411,100,000.0 | -912,900,000.0 | -389,900,000.0 | — |
| Financing Activities | -1,695,900,000.0 | -1,304,200,000.0 | -848,100,000.0 | -861,800,000.0 | — |